{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:27:06Z","timestamp":1773098826236,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T00:00:00Z","timestamp":1447632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141253","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T17:51:29Z","timestamp":1447696289000},"page":"e0141253","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["Abnormal Protein Glycosylation and Activated PI3K\/Akt\/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics"],"prefix":"10.1371","volume":"10","author":[{"given":"C\u00e9u","family":"Costa","sequence":"first","affiliation":[]},{"given":"Sofia","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"Elisabete","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Diogo","family":"Neves","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Neves","sequence":"additional","affiliation":[]},{"given":"Cristiana","family":"Gaiteiro","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Tavares","sequence":"additional","affiliation":[]},{"given":"Rui M.","family":"Gil da Costa","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Cruz","sequence":"additional","affiliation":[]},{"given":"Teresina","family":"Amaro","sequence":"additional","affiliation":[]},{"given":"Paula A.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Alexandre","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"L\u00facio L.","family":"Santos","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"key":"ref1","first-page":"31","article-title":"Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history","volume":"10","author":"E Pasin","year":"2008","journal-title":"Rev Urol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"M Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.14194\/ijmbr.235","article-title":"A review of molecular biomarkers for bladder cancer","volume":"2","author":"I Miakhil","year":"2013","journal-title":"Int J Med Biomed Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10555-009-9192-9","article-title":"Emerging targeted therapies for bladder cancer: a disease waiting for a drug","volume":"28","author":"SJ Dovedi","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molonc.2013.03.001","article-title":"Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours","volume":"7","author":"JA Ferreira","year":"2013","journal-title":"Mol Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molonc.2014.02.008","article-title":"Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells","volume":"8","author":"MA Carrascal","year":"2014","journal-title":"Mol Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2741\/3951","article-title":"Mechanisms of cancer-associated glycosylation changes","volume":"17","author":"F Dall\u2019Olio","year":"2012","journal-title":"Front Biosci (Landmark Ed"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/onc.2014.7","article-title":"Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia","volume":"34","author":"H Ma","year":"2015","journal-title":"Oncogene"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR Signaling in Cancer","volume":"4","author":"C Porta","year":"2014","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/labinvest.2010.133","article-title":"Expanding therapeutic targets in bladder cancer: the PI3K\/Akt\/mTOR pathway","volume":"90","author":"CB Ching","year":"2010","journal-title":"Lab Invest. Nature Publishing Group"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1464-410X.2004.04574.x","article-title":"The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion","volume":"93","author":"X Wu","year":"2004","journal-title":"BJU Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1038\/onc.2008.248","article-title":"The role of PTEN signaling perturbations in cancer and in targeted therapy","volume":"27","author":"M Keniry","year":"2008","journal-title":"Oncogene"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/jnci\/91.21.1820","article-title":"PTEN gene and integrin signaling in cancer","volume":"91","author":"M Tamura","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1080\/15287394.2012.690325","article-title":"Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines","volume":"75","author":"R Pinto-Leite","year":"2012","journal-title":"J Toxicol Env Heal A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.humpath.2013.07.008","article-title":"Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma","volume":"44","author":"E Munari","year":"2013","journal-title":"Hum Pathol. Elsevier Inc."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"166.e9","DOI":"10.1016\/j.urolonc.2014.12.006","article-title":"Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder","volume":"33","author":"M Nishikawa","year":"2015","journal-title":"Urol Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.urology.2012.09.007","article-title":"High levels of phosphatase and tensin homolog expression are associated with tumor progression, tumor recurrence, and systemic metastases in pt1 urothelial carcinoma of the bladder: A tissue microarray study of 156 patients treated by transurethral resect","volume":"81","author":"A Chaux","year":"2013","journal-title":"Urology"},{"key":"ref18","first-page":"3221","article-title":"The effects of sirolimus on urothelial lesions chemically induced in ICR mice by BBN","volume":"29","author":"PA Oliveira","year":"2009","journal-title":"Anticancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/bjc.2013.571","article-title":"Response of high-risk of recurrence\/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy","volume":"109","author":"L Lima","year":"2013","journal-title":"Br J Cancer"},{"key":"ref20","first-page":"727","article-title":"BBN as an urothelial carcinogen","volume":"26","author":"C Vasconcelos-N\u00f3brega","year":"2012","journal-title":"In Vivo (Brooklyn)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3892\/ol_00000066","article-title":"Biological similarities between murine chemical-induced and natural human bladder carcinogenesis","volume":"1","author":"C Palmeira","year":"2010","journal-title":"Oncol Lett"},{"key":"ref22","article-title":"Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review","author":"R Azevedo","year":"2015","journal-title":"J Control Release"},{"key":"ref23","first-page":"2189","article-title":"Expression of mucin-associated carbohydrate core antigens in esophageal squamous cell carcinomas","volume":"21","author":"U Flucke","year":"2001","journal-title":"Anticancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-0215(19960126)65:3<295::AID-IJC3>3.0.CO;2-V","article-title":"Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer","volume":"65","author":"M Victorzon","year":"1996","journal-title":"Int J Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/bjs.1800820734","article-title":"Correlation between expression of sialosyl-T antigen and survival in patients with gastric cancer","volume":"82","author":"A Tsuchiya","year":"1995","journal-title":"Br J Surg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2006.08.010","article-title":"Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells","volume":"249","author":"S Pinho","year":"2007","journal-title":"Cancer Lett"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/glycob\/cwj033","article-title":"ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity","volume":"16","author":"S Julien","year":"2006","journal-title":"Glycobiology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1423-0127-16-105","article-title":"Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome","volume":"16","author":"J-C Lin","year":"2009","journal-title":"J Biomed Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1464-410X.2012.11569.x","article-title":"A comprehensive immunohistochemical and molecular approach to the PI3K\/AKT\/mTOR (phosphoinositide 3-kinase\/v-akt murine thymoma viral oncogene\/mammalian target of rapamycin) pathway in bladder urothelial carcinoma","volume":"110","author":"P Korkolopoulou","year":"2012","journal-title":"BJU Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.humpath.2012.11.026","article-title":"Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non\u2013muscle invasive bladder cancer","volume":"44","author":"M Fahmy","year":"2013","journal-title":"Hum Pathol. Elsevier Inc."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2559.2011.03856.x","article-title":"Activation of the PI3K\/Akt\/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder","volume":"58","author":"CH Sun","year":"2011","journal-title":"Histopathology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1073\/pnas.0702507104","article-title":"Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity","volume":"104","author":"LH Saal","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/mc.20420","article-title":"Analysis of the Expression of Biomarkers in Urinary Bladder Cancer Using a Tissue Microarray","volume":"47","author":"L Harris","year":"2008","journal-title":"Mol Carcinog"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/ijc.28518","article-title":"PI3K\/AKT pathway activation in bladder carcinogenesis","volume":"134","author":"J Calderaro","year":"2014","journal-title":"Int J cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1016\/S1569-9056(14)60510-8","article-title":"Patient-derived sialyl-Tn positive invasive bladder cancer xenografts in nude mice: An exploratory model study","volume":"13","author":"J Ferreira","year":"2014","journal-title":"Eur Urol Suppl. European Association of Urology"},{"key":"ref36","article-title":"The route to personalized medicine in bladder cancer: where do we stand?","author":"F Massari","year":"2015","journal-title":"Target Oncol"},{"key":"ref37","first-page":"2214","article-title":"Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2\u2014\u20146 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope","volume":"48","author":"T Kjeldsen","year":"1988","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2015.05.003","article-title":"New trends in guided nanotherapies for digestive cancers: A systematic review","volume":"209","author":"E Fernandes","year":"2015","journal-title":"J Control Release"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T21:56:23Z","timestamp":1540331783000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141253"}},"subtitle":[],"editor":[{"given":"Francisco X.","family":"Real","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2015,11,16]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141253","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,16]]}}}